Page 6 of 84
OB OY YL VEN? CAVE COMPLEX FOUND UNDER GIZA PYRAMIDS development of the pyramid ield and the ancient Egyptians’ belief in an underworld. Collins's claim is expected o cause a stir in the Egyptological world. Dr Zahi Hawass, chief o Egypt's Supreme Council o} Antiquities, has dismissed he discovery. "There are no new discoveries to be made a Giza. We know everything about the plateau," he stated. But Collins remarks tha after extensive research, he found no mention of the caves in modern times. A enormous system of « caves, chambers and unnels lies hidden beneath he Pyramids of Giza, according to British explorer Andrew Collins who claims o have found the lost underworld of the pharaohs. Collins, who will detail his indings in the book Beneath he Pyramids, to be published in September, tracked down he entrance to the mysterious underworld after reading the forgotten memoirs of a 19th-century diplomat and explorer. "In his memoirs, British Consul-General Henry Salt recounts ow he investigated an underground system of ‘catacombs’ at Giza in 817 in the company of Italian explorer Giovanni Caviglia,” Collins said. The document records that the wo explored the caves for a distance of "several hundred yards", coming upon four large chambers rom which stretched further cave Egyptologist Nigel Skinner-Simpson, Collins reconstructed Salt's exploration on the plateau, eventually locating the entrance to the lost catacombs in an apparently unrecorded tomb west of the Great Pyramid. Indeed, the tomb featured a crack in the rock, which led into a massive natural cave. According to Collins, the caves— which are tens of thousands, if not hundreds of thousands of years old—may have inspired both the (Source: Discovery News, 13 August 2009, Attp://tinyurl.com/ovfs5cx; see also www.andrewcollins.com) on TAMOXIFEN INCREASES RISK OF RARE TUMOUR BY 440% Breast cancer patients given tamoxifen are more than four times more likely to develop a more aggressive tumour than those not prescribed the drug, scientists have warned. A study of over 1,000 patients found that the oestrogen-blocking drug reduced the risk of the most common, easy-to-treat cancer recurring by 60 per cent. But the chances of a rarer type not sensitive to the female hormone appearing in the opposite breast increased by an alarming 440 per cent. These are known as ER negative tumours, as opposed to ER positive, and are much more dangerous as there are no drugs that specifically target them. Dr Christopher Li, of the Fred Hutchinson Cancer Research Center in Seattle, USA, said: "This is of concern, given the poorer prognosis of ER-negative tumours, which are also more difficult to treat." (Source: Daily Mail Online, London, 26 August 2009) passageways. With the help British of somerville oe ») a+ _ ae — --. f You ARE vet) DRIVING OVER | A CLIFF... — GPS GOLDEN MoMENTS 6 * NEXUS OCTOBER - NOVEMBER 2009 www.nexusmagazine.com